Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pulmonary vessel tone refers to the degree of constriction or relaxation of the pulmonary blood vessels, particularly the arterioles. It is a key determinant of pulmonary vascular resistance (PVR), which regulates blood flow through the lungs and influences gas exchange efficiency. Regulation involves both passive mechanisms and active mechanisms involving vascular smooth muscle cells and endothelial-derived vasoactive substances like nitric oxide, prostacyclin, and endothelin-1. Abnormal regulation contributes to pulmonary hypertension.
Regulation of pulmonary vascular smooth muscle contraction and relaxation via vasoactive mediators (NO, prostacyclin, endothelin-1) and intracellular signaling pathways (Rho kinase, Ca2+).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pulmonary Vessel Tone.